Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0,47%
1 067,36
+4,96
+0,47%
—1 062,401 064,141 071,991 061,02——
SIXC
Communications
SIXC
Communications
SIXC
-0,54%
603,48
-3,26
-0,54%
—606,74606,74609,84602,33——
SIXE
Energy
SIXE
Energy
SIXE
+0,54%
1 244,93
+6,72
+0,54%
—1 238,211 236,601 247,741 232,10——
SIXI
Industrials
SIXI
Industrials
SIXI
+0,68%
1 730,38
+11,77
+0,68%
—1 718,611 723,231 741,481 717,47——
SIXM
Financials
SIXM
Financials
SIXM
+0,33%
639,47
+2,10
+0,33%
—637,37638,27642,30638,27——
SIXR
Staples
SIXR
Staples
SIXR
+0,16%
854,95
+1,36
+0,16%
—853,59854,05858,19851,34——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0,11%
218,56
+0,23
+0,11%
—218,33218,33219,73217,15——
SIXT
Technology
SIXT
Technology
SIXT
+1,02%
3 631,59
+36,78
+1,02%
—3 594,813 620,103 657,473 615,34——
SIXU
Utilities
SIXU
Utilities
SIXU
+0,80%
915,77
+7,23
+0,80%
—908,54909,50917,35907,07——
SIXV
Health care
SIXV
Health care
SIXV
+1,19%
1 512,81
+17,81
+1,19%
—1 495,001 499,611 517,101 499,61——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,41%
2 408,21
+9,90
+0,41%
—2 398,312 406,822 421,802 404,22——
AFT:NZE
AFT Pharmaceuticals Ltd
NZ$3,88
-0,26%
(-0,0100) 1D
26 Mei, 16:44:10 GMT+12  ·   NZD
All symbols
SymbolPriceChange% Change
Generating top insights for AFT...
Open
NZ$3,86
High
NZ$3,89
Low
NZ$3,86
Mkt. cap
406,88 m
Avg. vol.
17,04 k
Volume
34,14 k
Dividend
0,64%
Quarterly dividend
NZ$0,01
Ex-dividend date
18 Jun. 2026
P/E ratio
23,32
52-wk high
NZ$3,90
52-wk low
NZ$2,51
EPS
NZ$0,17
Shares outstanding
104,87 m
No. of employees
119
News stories
From sources across the web
About AFT Pharmaceuticals Ltd
CEOHartley Atkinson
Employees119
Founded1997
Headquarters-
SectorPharmaceutical industry
Websiteaftpharm.com
Previous reportsAll values in NZD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in NZD
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
57,47 m
57,47 m
69,88 m
69,88 m
Cost of goods sold
32,63 m
32,63 m
39,45 m
39,45 m
Cost of revenue
32,63 m
32,63 m
39,45 m
39,45 m
Research and development expenses
3,06 m
3,06 m
2,48 m
2,48 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19,10 m
19,10 m
18,21 m
18,21 m
Operating expense
22,48 m
22,48 m
20,58 m
20,58 m
Total operating expenses
55,10 m
55,10 m
60,03 m
60,03 m
Operating income
2,37 m
2,37 m
9,85 m
9,85 m
Other non operating income
462,50 k
462,50 k
-505,00 k
-505,00 k
EBT including unusual items
2,22 m
2,22 m
8,72 m
8,72 m
EBT excluding unusual items
2,22 m
2,22 m
8,72 m
8,72 m
Income tax expense
856,50 k
856,50 k
3,04 m
3,04 m
Effective tax rate
38,61%
38,61%
34,88%
34,88%
Other operating expenses
318,00 k
318,00 k
-113,00 k
-113,00 k
Net income
1,65 m
1,65 m
5,72 m
5,72 m
Net profit margin
2,87%
2,87%
8,18%
8,18%
Earnings per share
-
-
-
-
Interest and investment income
2,50 k
2,50 k
-
-
Interest expense
-615,00 k
-615,00 k
-630,50 k
-630,50 k
Net interest expenses
-612,50 k
-612,50 k
-630,50 k
-630,50 k
Depreciation and amortization charges
-
-
-
-
EBITDA
3,07 m
3,07 m
10,57 m
10,57 m
Gain or loss from assets sale
-
-
472,50 k
472,50 k
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer